Best of BS Opinion: Going viral on vaccines, another data breach & more

Here are the best of Business Standard's opinion pieces for Tuesday

START-UPS, investors, markets, IPO, companies, funds
Illustration: Binay Sinha
Rajesh Kumar New Delhi
1 min read Last Updated : May 25 2021 | 6:30 AM IST
Vaccine hesitancy and the absence of Covid-appropriate behaviour, especially in rural and moffusil India, are becoming critical problems in controlling the wildfire spread of the second wave of the pandemic. In this context, our lead editorial argues that a sustained campaign is required to spread awareness across the country. Read here
 
I think every company has to look at its own business model and target investor base. What is clear is that by listing in the US, you cut out domestic Indian investors entirely, writes Akash Prakash
 
It is past time that proper data privacy regulations be implemented in India, which correctly penalise companies that fail to inform customers about data breaches, notes our second editorial
 

Quote

“Our supply agreements at this time are with national governments and supra-national organisations with allocation of doses and implementation within the country being a decision for local governments based on relevant health authority guidance.”

Pfizer Inc

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusBS OpinionCurated ContentCoronavirus VaccineVaccinationStart-upsunicorn companiesAir IndiaData breachData PrivacyHackingPfizer

Next Story